Stocktoria
BUDA JUICE, INC. (BUDA) earns a Piotroski F-score of 3/9 (weak financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $12.6M at a 28.0% net margin.
Beneish M-score: 0.89 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.53 |
| Retained earnings / assets | 0.238 |
| EBIT / assets | 0.694 |
| Equity / liabilities | 3.034 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| BUDA | BUDA JUICE, INC. | 3/9 | 12.1 | 32.1 | +11.8% |
| IPST | IP STRATEGY HOLDINGS, INC. | 4/9 | -5.21 | — | — |
| SRXH | SRX Global Inc. | 3/9 | -14.39 | — | -81.3% |
| IBG | Innovation Beverage Group Ltd | 3/9 | -8.53 | — | — |
| YHC | LQR House Inc. | 3/9 | 9.64 | — | — |
| ASII | Accredited Solutions, Inc. | 3/9 | — | — | — |
| JSDA | JONES SODA CO. | 3/9 | — | — | +42.2% |
About BUDA JUICE, INC.
Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.
FAQ
Is BUDA financially healthy?
BUDA JUICE, INC.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does BUDA pay a dividend?
No, BUDA JUICE, INC. does not currently pay a dividend.
How profitable is BUDA?
In FY2025, BUDA JUICE, INC. had a net margin of 28.0% and a return on equity of 94.5%.
What is BUDA's P/E ratio?
BUDA JUICE, INC.'s trailing price-to-earnings (P/E) ratio is about 32.1×, based on its latest annual earnings.
What is the analyst price target for BUDA?
The average Wall-Street price target for BUDA JUICE, INC. is $14.00, about 51.4% above the recent price, from 1 analysts.
Is BUDA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on BUDA JUICE, INC.: a Piotroski F-score of 3/9, an Altman Z″ in the safe zone, a P/E of about 32.1×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.